Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Policy and Practice Reviews

Published on 09 Oct 2024

Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.

in Drugs Outcomes Research and Policies

Devon Crittenden
Raquel Gallagher
Fernanda Milans del Bosch
David M. Fox
Laura B. Kleiman

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419772

2,955 views

Systematic Review

Published on 08 Oct 2024

Management of blood lipids in post-kidney transplant patients: a systematic review and network meta-analysis

in Drugs Outcomes Research and Policies

Bohan Luo
Shan Zhong
Xiaoxiao Wang
Pu Guo
Yifu Hou
Wenjia Di

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440875

1,369 views

Original Research

Published on 04 Oct 2024

Identifying and presenting key country-specific indicators related to medication adherence: a comprehensive study across European countries

in Drugs Outcomes Research and Policies

Tamás Ágh
Kristina Garuolienė
Anne Gerd Granas
João Gregório
Nilay Aksoy
Nataliia Khanyk
Maja Ortner Hadžiabdić
Przemyslaw Kardas
European Network to Advance Best Practices and Technology on Medication Adherence (ENABLE) Collaborators
Emma Aarnio

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390629

1,947 views
1 citation

Opinion

Published on 01 Oct 2024

Challenges for esketamine nasal spray in China: use and management

in Drugs Outcomes Research and Policies

Jianhong Wu
Jun Gu
Linghe Qiu
Xin Jin
Zhenhe Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1429435

1,171 views
1 citation

Original Research

Published on 01 Oct 2024

Analysis of criteria for choosing drug treatment strategies in allergic rhinitis

in Drugs Outcomes Research and Policies

Damian Grzegorzewski
Marharyta Sobczak
Michał Tołkacz
Rafał Pawliczak

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1340554

899 views

Original Research

Published on 01 Oct 2024

Development of an evaluation system for rational drug use in patients with chronic kidney disease using the Delphi method

in Drugs Outcomes Research and Policies

Wenjie Yao
Xiaolan Ye
Guobing Zhang
Yan Ren
Qilong Gao
Xinfeng Ren
Yao Liu
Ping Huang
Jianlan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1183118

869 views

Policy and Practice Reviews

Published on 30 Sep 2024

A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactions

in Drugs Outcomes Research and Policies

Leonie Bogaard
Kayan Tsoi
Bas van de Steeg
Esther F. A. Brandon
Lisanne Geers
Margreet van Herwaarden
Frank Jansman
Dominique Maas
Margje Monster-Simons
David S. Y. Ong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412692

2,068 views
1 citation

Original Research

Published on 30 Sep 2024

Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events

in Drugs Outcomes Research and Policies

Ben-Nian Huo
Ling Shu
Jian-Wen Xiao
Nan-Ge Yin
Mao-Lin Ai
Yun-Tao Jia
Lin Song

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1292163

3,327 views
1 citation

Original Research

Published on 26 Sep 2024

Enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma: a cost-effectiveness analysis from China based on the EV-302 trial

in Drugs Outcomes Research and Policies

Maojin You
Qiaoyan Zheng
Ying He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412292

1,627 views
1 citation

Original Research

Published on 26 Sep 2024

Gaucher disease in Brazil: a comprehensive 16 year retrospective study on survival, cost, and treatment insights

in Drugs Outcomes Research and Policies

Marcus Carvalho Borin
Juliana Alvares-Teodoro
Francisco Assis Acurcio
Augusto Afonso Guerra

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1433970

1,354 views

Original Research

Published on 25 Sep 2024

The dose of remimazolam combined with sufentanil for the induction of general anesthesia in obese patients undergoing bariatric surgery: an up-and-down sequential allocation trial

in Drugs Outcomes Research and Policies

Minghui Chen
Huiying Wang
Jiajun Sun
Tao Zhang
Xiaoyin Niu
Tingting Zhang
Jian Liu
Xuan Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411856

1,421 views

Editorial

Published on 25 Sep 2024

Editorial: Internet pharmacies and the online pharmacy market: trends, perspectives and challenges

in Drugs Outcomes Research and Policies

András Fittler
Norah Othman Abanmy
Anna Serefko
Inayat Ur Rehman
Róbert György Vida

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1489396

1,919 views

Original Research

Published on 24 Sep 2024

Mining and evaluation of adverse event signals for capmatinib based on the FAERS database

in Drugs Outcomes Research and Policies

Xinnan Chen
Ying Jiang
Haohao Zhu
Man Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1417661

1,921 views
2 citations

Original Research

Published on 23 Sep 2024

Cost-effectiveness analysis of direct oral anticoagulants versus low-molecular-weight heparin and no thromboprophylaxis in primary prevention of cancer-associated venous thromboembolism in China

in Drugs Outcomes Research and Policies

Yue Wu
TianChen Yin
GuiLin Jian
Tao Wan
Benhong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373333

1,300 views
1 citation

Original Research

Published on 20 Sep 2024

Improving the feasibility of deprescribing proton pump inhibitors: GPs’ insights on barriers, facilitators, and strategies

in Drugs Outcomes Research and Policies

Nuša Japelj
Lea Knez
Davorina Petek
Nejc Horvat

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1468750

1,231 views

Original Research

Published on 19 Sep 2024

The impact of EU public procurement regulations on tenders in Spain: a study with adalimumab

in Drugs Outcomes Research and Policies

F. J. Esplugues
I. Andújar
J. V. Esplugues

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447324

1,982 views